Jones 2019 MiP2019

From Bioblast
Jump to: navigation, search
MiPsociety
Role of mitochondria in altered metabolic fluxes in non-alcoholic fatty liver disease.

Link: MiP2019

Jones JG (2019)

Event: MiP2019

COST Action MitoEAGLE

The liver plays a central role in regulating the circulation of fat and glucose during feeding and fasting. Non-alcoholic fatty liver disease (NAFLD), a condition that is now endemic in most Western societies, is characterized by an initial accumulation of triglyceride in hepatocytes. This relatively benign condition can progress to the more severe nonalcoholic steatohepatitis (NASH) and ultimately may lead to cirrhosis or hepatocellular carcinoma.

This lecture will focus on the role that mitochondria play in the initial stages of NAFLD from the perspective of hepatic fatty acid synthesis and oxidation. Since both processes involve the hepatic Krebs cycle, we will review its activity and role in coordinating hepatic carbohydrate and lipid metabolism as well as maintaining the hepatocellular energy state. I will discuss whether mitochondrial substrate metabolism is a driver of NAFLD or if it is responding to increased substrate inflow from outside the liver. I will also review the latest data on how mitochondrial metabolism is altered during the progression of NAFLD.

Finally, and perhaps most importantly, I will try to connect mitochondrial metabolic flux measurements with the more direct assays of mitochondrial function such as membrane potential, oxidative capacity and coupling of electron transport with ATP synthesis. With this approach, I believe it will be possible to associate metabolic flux alterations with specific defects in mitochondrial structure and/or function.


Bioblast editor: Plangger M, Tindle-Solomon L


Labels: Pathology: Other 


Tissue;cell: Liver 

Enzyme: TCA cycle and matrix dehydrogenases  Regulation: Fatty acid 




Affiliations

Center Neurosciences, Coimbra Portuguese Diabetes Association, Lisbon, Portugal